Alcon has received FDA approval to market Patanase nasal spray for the relief of hay fever symptoms. The spray, which was cleared for patients 12 years of age and older, will be launched in May, the company said.
Published in Brief:
Attest Health Care Advisors
|NGS Provider Enrollment Rep||
National Government Services - WellPoint
|Program Manager II||
Tufts Health Plan/Network Health
|Director, Medicare Advantage/Medicare Part D Focus||
|Director of Clinical Research||
Regenesis Biomedical, Inc.